Becton Dickinson Investing Activities - Other 2010-2025 | BDX
Becton Dickinson annual/quarterly investing activities - other history and growth rate from 2010 to 2025. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
- Becton Dickinson investing activities - other for the quarter ending March 31, 2025 was $-0.179B, a 20.09% decline year-over-year.
- Becton Dickinson investing activities - other for the twelve months ending March 31, 2025 was $-1.035B, a 4.12% increase year-over-year.
- Becton Dickinson annual investing activities - other for 2024 was $-0.444B, a 16.23% increase from 2023.
- Becton Dickinson annual investing activities - other for 2023 was $-0.382B, a 114.61% increase from 2022.
- Becton Dickinson annual investing activities - other for 2022 was $-0.178B, a 25.35% increase from 2021.
Becton Dickinson Annual Investing Activities - Other
(Millions of US $) |
| 2024 |
$-444 |
| 2023 |
$-382 |
| 2022 |
$-178 |
| 2021 |
$-142 |
| 2020 |
$-257 |
| 2019 |
$-261 |
| 2018 |
$-217 |
| 2017 |
$-148 |
| 2016 |
$-133 |
| 2015 |
$-147 |
| 2014 |
$-84 |
| 2013 |
$-99 |
| 2012 |
$-99 |
| 2011 |
$-64 |
| 2010 |
$-82 |
| 2009 |
$-86 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$50.274B |
$20.178B |
|
Becton, Dickinson and Company, is a medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents. BD's operations consisted of three business segments: BD Medical, BD Diagnostics and BD Biosciences. The company's organizational structure was realigned to form two principal business segments: BD Medical, BD Life Sciences and BD Interventional. BD Medical: BD Medical's major product lines include needles, syringes and intravenous catheters for medication delivery and generic prefilled injectables. BD Life Sciences - BD Diagnostics provides products for the safe collection and transport of diagnostics specimens to detect a broad range of infectious diseases, healthcare-associated infections and cancer. BD Biosciences produces research and clinical tools that facilitate the study of cells to gain a better understanding of normal and disease processes. With the acquisition of C.R. Bard, BD added a new segment - BD Interventional.
|
